Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2025-12-25 @ 1:07 AM
NCT ID:
NCT04510493
Brief Title:
Canakinumab in Patients With COVID-19 and Type 2 Diabetes
Official Title:
Canakinumab in Patients With COVID-19 and Type 2 Diabetes - CanCovDia Trial
Acronym:
CanCovDia
Study:
NCT04510493
Protocol Section:
NCT04510493